These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36788737)

  • 1. Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis.
    Okamoto T; Murata Y; Hasegawa D; Yoshida M; Tanaka D; Ueda T; Hazama D; Oduori OS; Komori S; Takai T; Saito Y; Kotani T; Kosaka Y; Maniwa Y; Matozaki T
    Cancer Sci; 2023 May; 114(5):1871-1881. PubMed ID: 36788737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.
    Lim KPH; Milne P; Poidinger M; Duan K; Lin H; McGovern N; Abhyankar H; Zinn D; Burke TM; Eckstein OS; Chakraborty R; Sengal A; Scull B; Newell E; Merad M; McClain KL; Man TK; Ginhoux F; Collin M; Allen CE
    Blood Adv; 2020 Jan; 4(1):87-99. PubMed ID: 31899802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.
    Hogstad B; Berres ML; Chakraborty R; Tang J; Bigenwald C; Serasinghe M; Lim KPH; Lin H; Man TK; Remark R; Baxter S; Kana V; Jordan S; Karoulia Z; Kwan WH; Leboeuf M; Brandt E; Salmon H; McClain K; Poulikakos P; Chipuk J; Mulder WJM; Allen CE; Merad M
    J Exp Med; 2018 Jan; 215(1):319-336. PubMed ID: 29263218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
    Berres ML; Lim KP; Peters T; Price J; Takizawa H; Salmon H; Idoyaga J; Ruzo A; Lupo PJ; Hicks MJ; Shih A; Simko SJ; Abhyankar H; Chakraborty R; Leboeuf M; Beltrão M; Lira SA; Heym KM; Bigley V; Collin M; Manz MG; McClain K; Merad M; Allen CE
    J Exp Med; 2014 Apr; 211(4):669-83. PubMed ID: 24638167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
    Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
    Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.
    Sahm F; Capper D; Preusser M; Meyer J; Stenzinger A; Lasitschka F; Berghoff AS; Habel A; Schneider M; Kulozik A; Anagnostopoulos I; Müllauer L; Mechtersheimer G; von Deimling A
    Blood; 2012 Sep; 120(12):e28-34. PubMed ID: 22859608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children.
    Zeng K; Ohshima K; Liu Y; Zhang W; Wang L; Fan L; Li M; Li X; Wang Z; Guo S; Yan Q; Guo Y
    Hematol Oncol; 2017 Dec; 35(4):845-851. PubMed ID: 27597420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
    Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
    J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis.
    Xiao Y; van Halteren AGS; Lei X; Borst J; Steenwijk E; de Wit T; Grabowska J; Voogd R; Kemps P; Picarsic J; van den Bos C; Borst J
    Blood; 2020 Nov; 136(19):2188-2199. PubMed ID: 32750121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS
    Kamata T; Giblett S; Pritchard C
    Blood; 2017 Jul; 130(4):514-526. PubMed ID: 28550040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells.
    Hutter C; Kauer M; Simonitsch-Klupp I; Jug G; Schwentner R; Leitner J; Bock P; Steinberger P; Bauer W; Carlesso N; Minkov M; Gadner H; Stingl G; Kovar H; Kriehuber E
    Blood; 2012 Dec; 120(26):5199-208. PubMed ID: 23074278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD207
    Carrera Silva EA; Nowak W; Tessone L; Olexen CM; Ortiz Wilczyñski JM; Estecho IG; Elena G; Errasti AE; Rosso DA
    Blood; 2017 Oct; 130(17):1898-1902. PubMed ID: 28847997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF-V600E utilizes posttranscriptional mechanisms to amplify LPS-induced TNFα production in dendritic cells in a mouse model of Langerhans cell histiocytosis.
    Minichino D; Lv K; Chu N; Tong W; Behrens EM
    J Leukoc Biol; 2022 Nov; 112(5):1089-1104. PubMed ID: 35648675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased AXL
    Olexen CM; Risnik D; Lava MC; Dalla Vecchia GL; Rosso DA; Errasti AE; Carrera Silva EA
    Clin Immunol; 2024 Jun; 263():110203. PubMed ID: 38575046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.
    Kemps PG; Zondag TCE; Arnardóttir HB; Solleveld-Westerink N; Borst J; Steenwijk EC; van Egmond D; Swennenhuis JF; Stelloo E; Trambusti I; Verdijk RM; van Noesel CJM; Cleven AHG; Scheijde-Vermeulen MA; Koudijs MJ; Krsková L; Hawkins C; Egeler RM; Brok J; von Bahr Greenwood T; Svojgr K; Beishuizen A; van Laar JAM; Pötschger U; Hutter C; Sieni E; Minkov M; Abla O; van Wezel T; van den Bos C; van Halteren AGS
    Blood Adv; 2023 Feb; 7(4):664-679. PubMed ID: 36083130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis.
    Paredes SEY; Almeida LY; Trevisan GL; Polanco XBJ; Silveira HA; Vilela Silva E; Segato RAB; da Silva LAB; Chahud F; León JE
    Scand J Immunol; 2020 Dec; 92(6):e12950. PubMed ID: 32738155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH.
    Sengal A; Velazquez J; Hahne M; Burke TM; Abhyankar H; Reyes R; Olea W; Scull B; Eckstein OS; Bigenwald C; Bollard CM; Yu W; Merad M; McClain KL; Allen CE; Chakraborty R
    Blood; 2021 Apr; 137(13):1777-1791. PubMed ID: 33075814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs.
    Washio K; Kotani T; Saito Y; Respatika D; Murata Y; Kaneko Y; Okazawa H; Ohnishi H; Fukunaga A; Nishigori C; Matozaki T
    Genes Cells; 2015 Jun; 20(6):451-63. PubMed ID: 25818708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the BRAFV600E mutation in 19 cases of Langerhans cell histiocytosis in Japan.
    Sasaki Y; Guo Y; Arakawa F; Miyoshi H; Yoshida N; Koga Y; Nakashima K; Kurita D; Niino D; Seto M; Ohshima K
    Hematol Oncol; 2017 Sep; 35(3):329-334. PubMed ID: 27041734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring Circulating CD207
    Olexen CM; Rosso DA; Nowak W; Fortunati D; Errasti AE; Carrera Silva EA
    J Immunol; 2022 Jul; 209(2):270-279. PubMed ID: 35768149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.